Hurley Capital LLC Has $1.76 Million Stock Position in Encompass Health Corporation (NYSE:EHC)

Key Points

• Hurley Capital LLC reduced its stake in Encompass Health Corporation by 13.9%, now holding 17,421 shares valued at approximately $1.76 million.
• Several research analysts have optimistic forecasts for Encompass Health, with upgrades in price targets, including KeyCorp's target increase from $122.00 to $135.00.
• Encompass Health recently announced an increase in its quarterly dividend from $0.17 to $0.19 per share, reflecting a positive trend in its financial management.

Hurley Capital LLC reduced its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 13.9% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 17,421 shares of the company's stock after selling 2,805 shares during the quarter. Encompass Health comprises 1.3% of Hurley Capital LLC's holdings, making the stock its 18th biggest position. Hurley Capital LLC's holdings in Encompass Health were worth $1,764,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Arlington Trust Co LLC increased its stake in shares of Encompass Health by 22.9% in the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after acquiring an additional 125 shares during the last quarter. IFP Advisors Inc increased its stake in shares of Encompass Health by 5.9% in the 1st quarter. IFP Advisors Inc now owns 2,814 shares of the company's stock valued at $285,000 after acquiring an additional 158 shares during the last quarter. Merit Financial Group LLC increased its stake in Encompass Health by 4.1% during the 1st quarter. Merit Financial Group LLC now owns 4,220 shares of the company's stock worth $427,000 after purchasing an additional 166 shares in the last quarter. Sequoia Financial Advisors LLC increased its stake in Encompass Health by 6.7% during the 1st quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock worth $276,000 after purchasing an additional 172 shares in the last quarter. Finally, Xponance Inc. increased its stake in Encompass Health by 1.6% during the 1st quarter. Xponance Inc. now owns 11,604 shares of the company's stock worth $1,175,000 after purchasing an additional 187 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, insider Elissa Joy Charbonneau sold 4,279 shares of the firm's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the sale, the insider owned 11,958 shares of the company's stock, valued at $1,394,422.38. This trade represents a 26.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Mark J. Tarr sold 118,384 shares of the firm's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the sale, the chief executive officer directly owned 527,070 shares of the company's stock, valued at $64,054,817.10. This represents a 18.34% decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.00% of the company's stock.

Encompass Health Stock Down 0.9%

Shares of NYSE EHC traded down $1.03 during trading hours on Friday, hitting $109.08. The company had a trading volume of 583,430 shares, compared to its average volume of 806,497. The stock has a market capitalization of $10.99 billion, a P/E ratio of 22.54, a price-to-earnings-growth ratio of 2.23 and a beta of 0.88. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.81. Encompass Health Corporation has a 1-year low of $82.74 and a 1-year high of $123.13. The firm's 50 day moving average is $117.08 and its 200-day moving average is $107.85.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $0.76 annualized dividend and a yield of 0.7%. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's payout ratio is 15.70%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on EHC shares. Royal Bank Of Canada increased their target price on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Truist Financial reissued a "buy" rating and set a $135.00 target price (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a research note on Thursday, June 5th. Barclays upped their price target on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. Finally, UBS Group upped their price target on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Seven research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $131.50.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.